Umbilical vessel catheter are the thin flexible tube made of medical grade material which is used to place in the blood vessel in the stump of a newborn’s umbilical cord. Umbilical vessel catheter are used for the treatment of new born premature babies. Umbilical vessel catheter act as an open passage which allows doctors to perform the treatment more easily. These catheters are used to provide special medication, fluids, and nutrition to the neonatal. Umbilical vessel catheters are basically of two types, viz. Umbilical artery catheter (UAC) and umbilical venous catheter (UVC). Umbilical artery catheter is inserted into the artery of the umbilical cord to withdraw the blood sample and monitoring the blood pressure. Umbilical artery catheter requires fewer needle sticks to withdraw the blood sample. The umbilical venous catheter is inserted into the vein of the umbilical cord to provide the fluid and medication to the neonatal. Umbilical venous catheter requires deep insertion to deliver the medication and fluid to the neonatal. As per FDA guidelines, the umbilical vessel catheter can be used for only 7 or less days, if the further treatment requires then doctors need to insert the peripheral catheter through leg or arm.
The increase in the number of premature deliveries throughout the globe and rise in the number of neonatal care center are the primary factors driving the growth of umbilical vessel catheter market. The umbilical cord has no pain receptor, therefore insertion of umbilical vessel catheter is not painful for the neonatal. Moreover, umbilical vessel catheter requires fewer needle sticks during the treatment. This factors will increase the demand of umbilical vessel catheter for the treatment of premature neonatal. The increased focus of medical devices manufacturers for the research and development on the neonatal products will boost the growth of this market. Continuous blood pressure monitoring and sample collection of blood gases can be done easily by using the umbilical vesselcatheter which will again upsurge the demand for this market. The risk of infection and blood clotting during the treatment by using umbilical vessel catheter will sluggish the growth of this market. Besides that lack of skilled professionals to handle umbilical vessel catheters and high cost of product will hamper the growth of this market over the forecast period.
The umbilical vessel catheter market is expected show exponential growth due to rise in healthcare expenditure for neonatal care. According to WHO, 15 million babies are born prematurely every year and this number tends to increase over the forecast period. WHO also stated that three-quarter of prematurely born babies have been saved in 2016 by using cost effective intervention. The umbilical vessel market is segmented on the basis of product type and end user. Based on the end user, umbilical vessel catheter is classified as umbilical artery catheter and umbilical venous catheter. Both umbilical venous catheter and umbilical artery catheter are expected to gain nearly equal market share. Based on end user umbilical vessel catheters market is classified as hospitals and neonatal care center. Among all end, user hospital is expected to gain maximum market share over the forecast period.
Based on geographic region Umbilical Vessel Catheters market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. The APEJ region is expected gain maximum market share due high number of premature birth in India and China. North America is the second most lucrative region umbilical vessel catheters market owing to rise in number of neonatal care center and favorable reimbursements scenario. After North America, this market is then followed by Western Europe and Japan. The Middle East & Africa region is the least lucrative market for umbilical vessel catheter due to lack of awareness among the people and less healthcare infrastructure.
Examples of some of the market participants in umbilical vessel catheters market identified across the value chain include Medtronic PLC, Vygon SA, Neotech Products, Anthelio Healthcare Solutions Inc., SURU International Pvt. Ltd., Utah Medical Products, Inc., Centurion Medical Products., and Hummingbird Medical.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global Umbilical Vessel Catheters market is classified on the basis of product type, end user and geographic region.
Based on product type, Umbilical Vessel Catheters market is segmented into following:
Based on end user, Umbilical Vessel Catheters market is segmented into following
Explore Similar Insights
Umbilical Vessel Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
